Who owns Avalo Therapeutics, Inc.?
Institutional ownership of AVTX from SEC Form 13F filings across 81 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
81
13F holders
$685.5M
value, 2026 filers
73.1%
of shares outstanding (38.4M sh)
37
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of AVTX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 5.1M | $94.3M | 0.0% | 9.7% | +77.1% |
| 2 | BlackRock, Inc. | 4.4M | $80.7M | 0.0% | 8.3% | +1234.7% |
| 3 | Deep Track Capital, LPNEW | 3.6M | $66.7M | 1.0% | 6.9% | new |
| 4 | TCG Crossover Management, LLC | 3.0M | $55.8M | 1.3% | 5.7% | +308.6% |
| 5 | Point72 Asset Management, L.P. | 2.4M | $44.1M | 0.0% | 4.5% | +160.6% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 2.3M | $41.8M | 0.0% | 4.3% | +57.3% |
| 7 | BANK OF AMERICA CORP /DE/ | 1.9M | $35.4M | 0.0% | 3.6% | +197.6% |
| 8 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.7M | $32.0M | 0.0% | 3.3% | +102.5% |
| 9 | PRICE T ROWE ASSOCIATES INC /MD/NEW | 1.3M | $24,241 | 0.0% | 2.5% | new |
| 10 | ALLIANCEBERNSTEIN L.P.NEW | 1.3M | $23.3M | 0.0% | 2.4% | new |
| 11 | UBS Group AG | 1.2M | $22.3M | 0.0% | 2.3% | +5.9% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 1.1M | $20.4M | 0.0% | 2.1% | +550.5% |
| 13 | GOLDMAN SACHS GROUP INC | 946,320 | $17.5M | 0.0% | 1.8% | +1474.4% |
| 14 | AMERIPRISE FINANCIAL INC | 891,405 | $16.5M | 0.0% | 1.7% | +417.8% |
| 15 | Balyasny Asset Management L.P. | 861,711 | $15.9M | 0.0% | 1.6% | +17.8% |
| 16 | BOOTHBAY FUND MANAGEMENT, LLC | 702,051 | $13.0M | 0.2% | 1.3% | +116.5% |
| 17 | Squarepoint Ops LLC | 589,245 | $10.9M | 0.0% | 1.1% | +624.9% |
| 18 | SILVERARC CAPITAL MANAGEMENT, LLCNEW | 500,402 | $9.2M | 1.0% | 1% | new |
| 19 | FRANKLIN RESOURCES INCNEW | 404,191 | $7.5M | 0.0% | 0.8% | new |
| 20 | NORTHERN TRUST CORP | 344,521 | $6.4M | 0.0% | 0.7% | +1027.5% |
| 21 | VANGUARD FIDUCIARY TRUST CO | 324,808 | $6.0M | 0.0% | 0.6% | +275.8% |
| 22 | CITADEL ADVISORS LLC | 323,833 | $6.0M | 0.0% | 0.6% | +67.2% |
| 23 | Schonfeld Strategic Advisors LLCNEW | 310,008 | $5.7M | 0.0% | 0.6% | new |
| 24 | VANGUARD PORTFOLIO MANAGEMENT LLCNEW | 284,702 | $5.3M | 0.0% | 0.5% | new |
| 25 | Caption Management, LLC | 210,000 | $3.9M | 0.0% | 0.4% | -53.8% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.